Perritt Capital Management Inc. Has $1.25 Million Position in Northeast Bancorp (NASDAQ:NBN)

Share on StockTwits

Perritt Capital Management Inc. lessened its stake in Northeast Bancorp (NASDAQ:NBN) by 4.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 45,286 shares of the financial services provider’s stock after selling 1,900 shares during the period. Perritt Capital Management Inc.’s holdings in Northeast Bancorp were worth $1,249,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Northern Trust Corp increased its position in shares of Northeast Bancorp by 5.3% during the second quarter. Northern Trust Corp now owns 90,654 shares of the financial services provider’s stock worth $2,500,000 after buying an additional 4,603 shares during the period. Renaissance Technologies LLC lifted its holdings in Northeast Bancorp by 17.3% in the second quarter. Renaissance Technologies LLC now owns 284,745 shares of the financial services provider’s stock valued at $7,853,000 after buying an additional 41,900 shares during the period. Pacific Ridge Capital Partners LLC boosted its position in Northeast Bancorp by 0.3% during the second quarter. Pacific Ridge Capital Partners LLC now owns 297,413 shares of the financial services provider’s stock valued at $8,203,000 after acquiring an additional 969 shares during the last quarter. Russell Investments Group Ltd. boosted its position in Northeast Bancorp by 5.4% during the second quarter. Russell Investments Group Ltd. now owns 233,043 shares of the financial services provider’s stock valued at $6,399,000 after acquiring an additional 12,017 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its position in Northeast Bancorp by 63.8% during the second quarter. Acadian Asset Management LLC now owns 49,126 shares of the financial services provider’s stock valued at $1,355,000 after acquiring an additional 19,134 shares during the last quarter. Hedge funds and other institutional investors own 63.73% of the company’s stock.

Northeast Bancorp stock traded up $0.24 during trading hours on Wednesday, reaching $21.99. 1,538 shares of the company’s stock were exchanged, compared to its average volume of 16,314. The firm’s 50 day simple moving average is $20.88 and its 200 day simple moving average is $21.03. Northeast Bancorp has a twelve month low of $15.54 and a twelve month high of $27.58. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $194.63 million, a PE ratio of 9.97 and a beta of 1.14.

Northeast Bancorp (NASDAQ:NBN) last announced its quarterly earnings data on Tuesday, July 30th. The financial services provider reported $0.59 earnings per share (EPS) for the quarter. Northeast Bancorp had a return on equity of 13.41% and a net margin of 15.79%. The company had revenue of $18.44 million for the quarter.

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Friday, August 16th were paid a dividend of $0.01 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $0.04 annualized dividend and a yield of 0.18%.

Northeast Bancorp Profile

Northeast Bancorp operates as the bank holding company for Northeast Bank that provides banking products and services to individual and corporate customers in the United States. The company's deposit products include noninterest-bearing demand deposit, savings, NOW, and money market accounts, as well as certificate of deposit accounts.

Featured Article: Coverage Ratio

Want to see what other hedge funds are holding NBN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Northeast Bancorp (NASDAQ:NBN).

Institutional Ownership by Quarter for Northeast Bancorp (NASDAQ:NBN)

Receive News & Ratings for Northeast Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northeast Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

ValuEngine Upgrades Blackbaud  to “Strong-Buy”
ValuEngine Upgrades Blackbaud to “Strong-Buy”
Anavex Life Sciences  Upgraded to “Buy” by ValuEngine
Anavex Life Sciences Upgraded to “Buy” by ValuEngine
Cantor Fitzgerald Boosts Adverum Biotechnologies  Price Target to $8.00
Cantor Fitzgerald Boosts Adverum Biotechnologies Price Target to $8.00
Citigroup Trims Mplx  Target Price to $32.00
Citigroup Trims Mplx Target Price to $32.00
Evofem Biosciences  Downgraded to Hold at Zacks Investment Research
Evofem Biosciences Downgraded to Hold at Zacks Investment Research
Zacks Investment Research Upgrades Cushman & Wakefield  to “Hold”
Zacks Investment Research Upgrades Cushman & Wakefield to “Hold”


 
© 2006-2019 Zolmax.